Convalescent Plasma in a Patient with Protracted COVID-19 and Secondary Hypogammaglobulinemia Due to Chronic Lymphocytic Leukemia: Buying Time to Develop Immunity?

It is not exactly clear yet which type of immune response prevails to accomplish viral clearance in coronavirus disease 2019 (COVID-19). Studying a patient with chronic lymphocytic leukemia and hypogammaglobulinemia who suffered from COVID-19 provided insight in the immunological responses after tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanssen, Jaap L. J., Stienstra, Johan, Boers, Stefan A., Pothast, Cilia R., Zaaijer, Hans L., Tjon, Jennifer M., Heemskerk, Mirjam H. M., Feltkamp, Mariet C. W., Arend, Sandra M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544405/
https://www.ncbi.nlm.nih.gov/pubmed/34698153
http://dx.doi.org/10.3390/idr13040077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544405/
https://www.ncbi.nlm.nih.gov/pubmed/34698153
http://dx.doi.org/10.3390/idr13040077

Ejemplares similares